diaminopimelic acid has been researched along with fk 156 in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (67.86) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 2 (7.14) | 29.6817 |
| 2010's | 5 (17.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolodziejczyk, AM; Kolodziejczyk, AS; Stoev, S | 1 |
| Dewdney, JM; Henderson, DC; Robertson, F; Seal, S; Spackman, V; Weston, BJ | 1 |
| Ahmed, K; Turk, JL; van der Meide, PH | 1 |
| Ivanitskaia, LP; Khurnova, LM | 1 |
| Ahmed, K; Turk, JL | 1 |
| Umezawa, H | 1 |
| Kikuchi, H; Mine, Y; Tawara, S; Watanabe, Y | 1 |
| Altom, MG; Schultz, RM | 1 |
| Leyhausen, G; Maidhof, A; Müller, WE; Tanaka, W; Umezawa, H; Weissmann, N | 1 |
| Aoki, H; Gotoh, T; Hashimoto, S; Imanaka, H; Izumi, S; Kino, T; Nakahara, K; Okuhara, M | 1 |
| Fukada, S; Goto, S; Kuwahara, S; Mine, Y; Nishida, M; Wakai, Y; Yokota, Y | 1 |
| Goto, S; Kuwahara, S; Mine, Y; Nishida, M; Wakai, Y; Watanabe, Y; Yokota, Y | 1 |
| Aratani, M; Hashimoto, M; Hemmi, K; Kitaura, Y; Okada, S; Takeno, H | 1 |
| Hashimoto, M; Hemmi, K; Kitaura, Y; Nakaguchi, O; Okada, S; Takeno, H; Yonishi, S | 1 |
| Goto, S; Kuwahara, S; Mine, Y; Nishida, M; Tawara, S; Watanabe, Y; Yokota, Y | 1 |
| Aoki, H; Gotoh, T; Hashimoto, M; Imanaka, H; Kino, T; Kohsaka, M; Kuroda, Y; Nakahara, K; Nishiura, T; Okuhara, M | 1 |
| Hashimoto, M; Hemmi, K; Kitaura, Y; Mine, Y; Mori, J; Nakaguchi, O; Okada, S; Senoh, H; Takeno, H; Yonishi, S | 1 |
| Aratani, M; Hashimoto, M; Hemmi, K; Kitaura, Y; Nakaguchi, O; Okada, S; Takeno, H; Yonishi, S | 1 |
| Aoki, H; Gotoh, T; Imanaka, H; Iwami, M; Nakahara, K | 1 |
| Gotoh, T; Imanaka, H; Kawai, Y; Nakahara, K; Tanaka, H; Uchida, I | 1 |
| Aratani, M; Hashimoto, M; Hemmi, K; Kitaura, Y; Miyazaki, Y; Nakaguchi, O; Okada, S; Takeno, H | 1 |
| Aiba, S; Ohteki, T; Shibata, K; Tada, H; Takada, H | 1 |
| Balloy, V; Carneiro, LA; Chignard, M; Decker, T; Fritz, JH; Girardin, SE; le Bourhis, L; Liu, J; Ma, X; Magalhaes, JG; Philpott, DJ; Stockinger, S; Werts, C | 1 |
| Asada, Y; Endo, Y; Funayama, H; Huang, L; Takada, H | 1 |
| Endo, Y; Sato, T; Shikama, Y; Shimauchi, H; Takada, H | 1 |
| Arai, H; Chiba, T; Kudo, M; Strober, W; Tsuji, Y; Watanabe, T | 1 |
| Boulianne, B; Duerr, CU; Fritz, JH; Gommerman, JL; McCarthy, DD; Mindt, BC; Ng, D; Paradis, M; Philpott, DJ; Rojas, OL; Summers deLuca, LE; Waldron, JB; Ward, LA; Yu, MD | 1 |
| Chiba, T; Ezoe, H; Kudo, M; Sadakane, Y; Sakurai, T; Strober, W; Watanabe, T; Yagama, N | 1 |
2 review(s) available for diaminopimelic acid and fk 156
| Article | Year |
|---|---|
[Low-molecular weight immunomodulators of microbial origin].
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Diaminopimelic Acid; Glycine; Guinea Pigs; Immunologic Deficiency Syndromes; Leucine; Mice; Molecular Weight; Neoplasms, Experimental; Oligopeptides | 1989 |
Low-molecular-weight immunomodifiers produced by micro-organisms.
Topics: Alkaline Phosphatase; Aminopeptidases; Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antibody Formation; Diaminopimelic Acid; Glycine; Guanidines; Hypersensitivity, Delayed; Immune Tolerance; Immunity; Immunity, Cellular; Lactones; Leucine; Leukemia L1210; Mice; Molecular Weight; Oligopeptides; Peptides; Polycyclic Sesquiterpenes; Sesquiterpenes; T-Lymphocytes, Regulatory | 1985 |
26 other study(ies) available for diaminopimelic acid and fk 156
| Article | Year |
|---|---|
New convenient synthesis of immunostimulating peptides containing meso-diaminopimelic acid. Syntheses of FK-565 and FK-156.
Topics: Adjuvants, Immunologic; Chromatography, High Pressure Liquid; Diaminopimelic Acid; Hydrolysis; Oligopeptides | 1992 |
Stimulatory effects of FK156 in a panel of tests designed to detect changes in immune function.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Diaminopimelic Acid; Immune System; Immunologic Tests; In Vitro Techniques; Lymphocyte Activation; Macrophage Activation; Male; Rats; Rats, Inbred F344 | 1991 |
Effect of anticancer drugs on the release of interferon gamma in vitro.
Topics: Animals; Antineoplastic Agents; Bleomycin; Concanavalin A; Cyclosporins; Diaminopimelic Acid; Doxorubicin; In Vitro Techniques; Interferon-gamma; Male; Oligopeptides; Rats; Rats, Inbred Lew; Vincristine | 1989 |
Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.
Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzodiazepinones; Diaminopimelic Acid; Dose-Response Relationship, Immunologic; Interleukin-1; Interleukin-2; Male; Oligopeptides; Rats; Rats, Inbred Lew; Spleen | 1989 |
Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Diaminopimelic Acid; Lysosomes; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Muramidase; Oligopeptides; Phagocytosis; Superoxides; T-Lymphocytes | 1985 |
Macrophage involvement in the antitumor activity of a synthetic acyltripeptide (FK-565) against experimental lung carcinoma metastases.
Topics: 2-Chloroadenosine; Adenosine; Adjuvants, Immunologic; Animals; Antineoplastic Agents; Diaminopimelic Acid; In Vitro Techniques; Lung Neoplasms; Lymphokines; Macrophage Activation; Macrophage-Activating Factors; Male; Mice; Mice, Inbred BALB C; Oligopeptides | 1986 |
Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Aminopeptidases; Amphotericin B; Animals; Anti-Bacterial Agents; Diaminopimelic Acid; Dipeptides; Glutamyl Aminopeptidase; Leucine; Leucyl Aminopeptidase; Lymphocyte Activation; Lymphocytes; Male; Mice; Mitogens; Oligopeptides; Peptides; Spleen | 1985 |
Antitumor effects of novel immunoactive peptides, FK-156 and its synthetic derivatives.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Antineoplastic Agents; Diaminopimelic Acid; Female; Interferons; Mice; Mice, Inbred DBA; Neoplasms, Experimental | 1983 |
Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Bacterial Infections; Candidiasis; Diaminopimelic Acid; Escherichia coli; Immunity, Innate; Listeria monocytogenes; Male; Mice; Mice, Inbred ICR; Oligopeptides; Structure-Activity Relationship | 1983 |
Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Antibiotics, Antineoplastic; Bacterial Infections; Carrageenan; Cyclophosphamide; Diaminopimelic Acid; Drug Synergism; Hydrocortisone; Immunity, Innate; Immunosuppression Therapy; Male; Mice; Mice, Inbred ICR; Mitomycin; Mitomycins; Oligopeptides; Phagocytosis; Sarcoma 180 | 1983 |
Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. I. Synthesis of stereoisomeric analogues of FK-156.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Diaminopimelic Acid; Mice; Stereoisomerism; Structure-Activity Relationship | 1984 |
Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. II. Synthesis of N2-(gamma-D-glutamyl)-2(L), 2'(D)-diaminopimelic acid as the minimal essential structure of FK-156.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Diaminopimelic Acid; Mice; Structure-Activity Relationship | 1984 |
Immunoactive peptides, FK-156 and FK-565. III. Enhancement of host defense mechanisms against infection.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Bacterial Infections; Candidiasis; Chemotaxis; Cyclophosphamide; Diaminopimelic Acid; Hydrocortisone; Immunity, Innate; Immunosuppression Therapy; Leukocyte Count; Macrophages; Male; Mice; Mice, Inbred ICR; Neutrophils; Oligopeptides; Phagocytosis | 1983 |
Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterization.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Antibody Formation; Antineoplastic Agents; Carbohydrate Metabolism; Chemical Phenomena; Chemistry; Chemistry, Physical; Diaminopimelic Acid; Escherichia coli Infections; Female; Fermentation; Guinea Pigs; Hypersensitivity, Delayed; Male; Mice; Mice, Inbred BALB C; Mitogens; Rats | 1982 |
N2-(gamma-D-Glutamyl)-meso-2(L),2'(D)-diaminopimelic acid as the minimal prerequisite structure of FK-156: its acyl derivatives with potent immunostimulating activity.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Diaminopimelic Acid; Female; Guinea Pigs; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Structure-Activity Relationship | 1982 |
Synthesis and RES-stimulating activity of bacterial cell-wall peptidoglycan peptides related to FK-156.
Topics: Amino Acids, Diamino; Animals; Biological Assay; Chemical Phenomena; Chemistry; Diaminopimelic Acid; Male; Mice; Peptidoglycan; Phagocytosis; Structure-Activity Relationship | 1982 |
Studies on a new immunoactive peptide, FK-156. I. Taxonomy of the producing strains.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Carbohydrate Metabolism; Diaminopimelic Acid; Spores, Fungal; Streptomyces | 1982 |
Studies on a new immunoactive peptide, FK-156. III. Structure elucidation.
Topics: Adjuvants, Immunologic; Amino Acids; Amino Acids, Diamino; Chemical Phenomena; Chemistry; Chemistry, Physical; Dansyl Compounds; Diaminopimelic Acid; Spectrophotometry, Infrared | 1982 |
Studies on a new immunoactive peptide, FK-156. IV. Synthesis of FK-156 and its geometric isomer.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Chemical Phenomena; Chemistry, Physical; Diaminopimelic Acid; Stereoisomerism | 1982 |
Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adaptor Proteins, Signal Transducing; Adjuvants, Immunologic; Cytokines; Dendritic Cells; Diaminopimelic Acid; Drug Synergism; Humans; Interleukin-12; Intracellular Signaling Peptides and Proteins; Lipid A; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Oligodeoxyribonucleotides; Oligopeptides; Poly I-C; Polylysine; RNA, Messenger; Th1 Cells; Toll-Like Receptors | 2005 |
Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Bone Marrow Cells; Cell Differentiation; Chemokine CCL5; Chemokines, CC; Diaminopimelic Acid; Female; I-kappa B Proteins; Interferon Type I; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Promoter Regions, Genetic; Signal Transduction | 2007 |
Enhanced induction of a histamine-forming enzyme, histidine decarboxylase, in mice primed with NOD1 or NOD2 ligand in response to various Toll-like receptor agonists.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Diaminopimelic Acid; Histamine; Histidine Decarboxylase; Indicators and Reagents; Lipid A; Lung; Male; Mice; Mice, Inbred BALB C; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Oligopeptides; Toll-Like Receptors | 2010 |
Analgesic effects of chemically synthesized NOD1 and NOD2 agonists in mice.
Topics: Acetic Acid; Acetylmuramyl-Alanyl-Isoglutamine; Analgesics; Animals; Diaminopimelic Acid; Drug Antagonism; Female; Interleukin-1; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Naloxone; Narcotic Antagonists; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Oligopeptides; Pain; Pain Measurement; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Acinar Cells; Animals; Bacteria; Ceruletide; Chemokine CCL2; Diaminopimelic Acid; Humans; Immunity, Mucosal; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mucous Membrane; NF-kappa B; Nod1 Signaling Adaptor Protein; Pancreatitis; Receptors, CCR2; Signal Transduction; STAT3 Transcription Factor | 2012 |
A TNF-α-CCL20-CCR6 axis regulates Nod1-induced B cell responses.
Topics: Animals; B-Lymphocytes; Bone Marrow Cells; Bone Marrow Transplantation; Cell Line; Cells, Cultured; Chemokine CCL20; Diaminopimelic Acid; Female; Flow Cytometry; Lymphocyte Count; Lymphoid Tissue; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Neutrophils; Nod1 Signaling Adaptor Protein; Receptors, CCR6; Spleen; Transplantation Chimera; Tumor Necrosis Factor-alpha | 2014 |
Nucleotide-binding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitis.
Topics: Acinar Cells; Animals; Ceruletide; Diaminopimelic Acid; Disease Models, Animal; Gene Expression Regulation; Interferon-gamma; Interleukin-13; Interleukin-33; Interleukin-4; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Nod1 Signaling Adaptor Protein; Pancreatitis, Chronic; Receptors, Cholecystokinin; Signal Transduction; Th2 Cells; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2016 |